Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 20,927,729 $ 16,966,168
Accounts receivable 573 0
Prepaid expenses 444,872 267,518
Other current assets 791,349 322,593
Total Current Assets 22,164,523 17,556,279
Property and equipment, net 3,343,297 2,981,225
Operating lease right-of-use assets 257,903 381,483
Intangible assets, net 321,848 372,305
Total Assets 26,087,571 21,291,292
Current Liabilities    
Accounts payable 849,146 627,253
Accrued liabilities 2,403,102 2,168,588
Management and directors' fees payable 47,675 21,979
Current portion of long-term debt 765,151 647,569
Current portion of finance lease liabilities 57,047 97,946
Current portion of operating lease liabilities 157,796 257,244
Current portion of grant repayable 37,992 39,295
Total Current Liabilities 4,317,909 3,859,874
Long-term debt, net of current portion 1,831,021 2,195,278
Finance lease liabilities, net of current portion 591,658 607,708
Operating lease liabilities, net of current portion 108,305 131,875
Grant repayable, net of current portion 277,267 297,991
Total Liabilities 7,126,160 7,092,726
STOCKHOLDERS' EQUITY    
Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 48,064,575 shares and 41,125,303 shares, respectively 48,065 41,125
Additional paid-in capital 124,121,703 103,853,627
Accumulated other comprehensive income (148,121) 125,670
Accumulated deficit (105,036,840) (89,821,856)
Total VolitionRx Limited Stockholders' Equity 18,984,807 14,198,566
Non-controlling interest (23,396) 0
Total Stockholders' Equity 18,961,411 14,198,566
Total Liabilities and Stockholders' Equity $ 26,087,571 $ 21,291,292